Member Info for Doc83

Slight shame it didn't close above £2, just from a psychological point of view.

Just getting greedy now!

Lol!

My best guess would be that this will trade anywhere between 175p - 250p between now and sprinter P3 readout.
I would be disappointed to see it go back to trading around 150p.

Crypto not for me. I don’t claim to know enough about it, and it’s a bit too volatile for my liking.

Bid/offer spread wider than a barn door. MM’s having everyone’s pants down.

Yes, it is still too risky to put the bulk of your investment money into. I have great conviction in SNG, but there are still plenty of risks. Political risks being one of them.

Great post BeContrarian.

But it doesn’t matter if you transmit it because for those who have been vaxxed they are safe, because the vaccines work… oh, wait…

I’m hoping for a steady rise in the share price now. The news last week and eventual move upwards for the SP will hopefully have attracted attention and continue to drive us on.

I originally bought in at 130p and have topped up that many times I’ve lost count. Most recent top ups were at 145p following Dr Castro’s last little hint, and then at 171p following the announcement of progression to phase 3 on Activ. I just thought they should have moved to at least £2 due to a big positive shift in the risk/reward ratio.

After the move yesterday, they now account for 20% of my overall portfolio. That is breaking my own rules on single stock exposure but my portfolio is growing rapidly due to extra disposable income to put into my investments on a monthly basis and I have conviction that this is a good stock with great prospects.

I’ve never had a true multi bagger (10x +) and would be over the moon if it was SNG who seem a great bunch and is also a company trying to do good things.

I’m in for the party, sign me up!

Andybe4, I think it added more like $20bn. They went from $75 to $82, with a market cap of about $200bn.

I can’t be the other misogynistic “doc” you mention. I’ve never be involved with any of these discussions previously.

There really are some snowflakes on here! The types who would probably be offended if Yorkie chocolate bars went back to the original “not for girls!” design…

Grow up and stop being so bloody sensitive.

I think the odds are decent of passing phase 3. But even if it’s 50/50, I would still say the risk to reward is favourable. Yes, you could lose £2 per share, but pass phase 3 and you win £10+.

Even if the very worst was to happen, I would hope all the data collected so far and expertise with interferon beta is worth something. So hopefully this would never go to £0.

Can this hit £20???

Oh fu*k, wrong account… thought I was on my Jwd222 account… ;)

YTD high about to go!

Well on a positive, the SP is getting close to the highs of 2021 and the US market hasn't even fired up yet today!

I also like NDN's posts. But no need to try make other posters look stupid which, intentionally or not, is how it can come across.

Anyway, back to this SP and it's moving along nicely!

I was arguing that the SP should have been higher on the back of the Activ-2 progression news. I think the fact the share price is now rising vindicates that thinking.

But yes, let’s leave it there. We ultimately all want SNG to succeed and I wish all LTH the best.

“The price should have moved much more positively following now of Activ-2 progression”

Should it? Why?”

Come on NDN71, now you’re being deliberately obtuse!

For the record, a LTH who has continued to put his money where his mouth is but isn’t naive enough to believe the markets always play fair and by the rules.

Matml74, great points and should puts minds at rest for those of us concerned if Polygon does keep buying up.

The price should have moved much more positively following now of Activ-2 progression, especially with Polygon now confirmed to have been heavily buying. Deal3r also explained what MM’s do, and I’m aware of some of the things brokers can do to manipulate prices.

I’ll say it again, I’m not concerned at the minute, I am here for the long term and until TO time. But it is healthier to have a diversified set of investors and not one giant holder of the shares.